Giardia vaccination

Parasitol Today. 2000 May;16(5):213-7. doi: 10.1016/s0169-4758(99)01623-3.

Abstract

Recently, a Giardia vaccine has become commercially available in the USA for prevention of clinical signs of giardiasis and reduction of cyst shedding in dogs and cats. The vaccine is based upon the current state of knowledge of Giardia antigenicity and immunology. Here, Merle Olson, Howard Ceri and Douglas Morck describe studies that led to the development of this vaccine and subsequent efficacy studies. Immunoprophylaxis and immunotherapeutic application of the vaccine are discussed.

Publication types

  • Review

MeSH terms

  • Animals
  • Antibodies, Protozoan / blood
  • Antigens, Protozoan / immunology
  • Cat Diseases / immunology
  • Cat Diseases / parasitology
  • Cat Diseases / prevention & control*
  • Cats
  • Dog Diseases / immunology
  • Dog Diseases / parasitology
  • Dog Diseases / prevention & control*
  • Dogs
  • Feces / parasitology
  • Female
  • Giardia lamblia / immunology*
  • Giardiasis / immunology
  • Giardiasis / prevention & control
  • Giardiasis / veterinary*
  • Humans
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Parasite Egg Count / veterinary
  • Protozoan Vaccines / immunology*
  • Protozoan Vaccines / standards
  • Vaccination / veterinary*

Substances

  • Antibodies, Protozoan
  • Antigens, Protozoan
  • Protozoan Vaccines